The company's upcoming earnings report is scheduled for Sunday, May 3rd, with a consensus estimate EPS of -0.36.
Inspire Medical Systems, Inc. (INSP) is currently trading at $55.16, showing a price change of 8.4999 cents (0.154%) since the previous close. The trading volume is $121,763, representing a 10.44% increase relative to the average.
The latest quarterly earnings report for INSP was on Tuesday, February 10th, with a consensus estimate EPS of 0.69. The company's net income stands at $136 million, with an EPS of $4.7.
INSP's cash flow highlights include operating cash flow of $52.47 million and free cash flow of $41.81 million. The net change in cash for the period is -$8 million.
The company reported revenue of $269 million, resulting in a net income of $136 million. EBITDA stands at $49.93 million, with an EPS of $4.7.
Key ratios for INSP include a net profit margin of 50.58%, return on assets of 14.82%, and a debt ratio of 6.77.
INSP's balance sheet shows total assets of $918.49 million, with total liabilities at $137.33 million. The company holds $104.81 million in cash and cash equivalents.
This real-time financial report provides insights into INSP's current performance and financial health, preparing investors for upcoming market movements.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.